[Islands cells are not activated quickly enough. Risk of obstruction of blood vessels].
D001161:Arteriosclerosis / Q000097:blood / Q000517:prevention & control; D001786:Blood Glucose / Q000378:metabolism*; D003510:Cyclohexanes / Q000008:administration & dosage*; D003925:Diabetic Angiopathies / Q000097:blood / Q000517:prevention & control; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance / Q000502:physiology*; D007515:Islets of Langerhans / Q000187:drug effects*; D008687:Metformin / Q000008:administration & dosage; D000077715:Nateglinide; D010649:Phenylalanine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D019518:Postprandial Period / Q000502:physiology*; D012306:Risk
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D000077715:Nateglinide; D010649:Phenylalanine; D008687:Metformin